A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Observational
Observational Model: Cohort, Time Perspective: Prospective
Safety - renal and hepatic function monitoring.
5 years
Yes
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals
United States: Food and Drug Administration
CICL670A2411
NCT00466063
May 2007
Name | Location |
---|---|
Stanford University Medical Center | Stanford, California 94305-5408 |
Hackensack University Medical Center | Hackensack, New Jersey 07601 |
Children's Hospital Los Angeles | Los Angeles, California 90027-0700 |
Children's Hospital of Orange County | Orange, California 92668 |
University of South Alabama Medical Center | Mobile, Alabama 36604 |
Schneider Children's Hospital | New Hyde Park, New York 11042 |
Children's Hospital of the King's Daughters | Norfolk, Virginia 23507 |
Akron Children's Hospital | Akron, Ohio 44308-1062 |
St. Joseph's Children's Hospital of Tampa | Tampa, Florida 33677-4227 |
Children's Hospital Boston | Boston, Massachusetts 02115 |
Texas Children's Hospital | Houston, Texas |
Children's Memorial Hospital | Chicago, Illinois 60614 |
Cook's Children's Medical Center | Fort Worth, Texas 76104 |
Children's Hospital Oakland | Oakland, California 94609 |
Children's Medical Center | Dayton, Ohio 45404 |
East Carolina University | Greenville, North Carolina 27858 |
MD Anderson Cancer Center - Orlando | Orlando, Florida 32806 |
St. Joseph's Children's Hospital | Paterson, New Jersey 07503 |
The Brooklyn Hospital Center | Brooklyn, New York 11201 |
SUNY - Upstate Medical University | Syracuse, New York 13210 |
Oklahoma State University Health Sciences Center | Oklahoma City, Oklahoma 73104 |
Penn State University / Milton S. Hershey Medical Center | Hershey, Pennsylvania 17033-0850 |
St. Jude Children's Research Hospital Memphis | Memphis, Tennessee 38105-2794 |